Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

ISAR-DESIRE 4 trial, TCT 2015, drug-coated balloon, DCB, scoring balloon, SCB, drug-eluting stent restenosis
Feature | Drug-Eluting Balloons

October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a paclitaxel-coated ...

Home October 22, 2015
Home
thrombus aspiration, STEMI patients, TCT 2015, TOTAL study
Feature | Thrombectomy Devices

October 20, 2015 — A pair of studies presented at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) ...

Home October 20, 2015
Home
BRAVO 3 trial results, bivalirudin, heparin, anticoagulation, TAVR, TCT 2015
Feature | Antiplatelet and Anticoagulation Therapies

October 20, 2015 — Results from the BRAVO 3 trial found that bivalirudin did not significantly reduce major bleeding ...

Home October 20, 2015
Home
Amaranth Fortitute Bioresorbable stent
Feature | TCT | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline

There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual ...

Home October 19, 2015
Home
transradial access, TRI, DRAGON trial, TCT 2015, non-inferiority, transfemoral access, TFO
Feature | Radial Access

October 18, 2015 — Results from a prospective randomized trial of transradial (TRI) versus transfemoral (TFO) access in ...

Home October 18, 2015
Home
FFR-CT, cost and quality of life outcomes, TCT 2015, PLATFORM trial
Feature | CT Angiography (CTA)

October 18, 2015 — New results from a multicenter, prospective study show that assessing fractional flow reserve ...

Home October 18, 2015
Home
IN.PACT SFA study, TCT 2015, drug-coated balloons, PTA, SFA disease, superficial femoral artery
Feature | Peripheral Artery Disease (PAD)

October 18, 2015 — Two-year results from the IN.PACT SFA study found the use of a drug-coated balloon was superior to co ...

Home October 18, 2015
Home
RESPECT trial, long-term study results, TCT 2015, PFO closure, recurrent cryptogenic stroke
Feature | Stroke

October 16, 2015 — Long-term study results from the RESPECT trial found that closing a patent foramen ovale (PFO) with ...

Home October 16, 2015
Home
News | Stents Bioresorbable

October 16, 2015 — Enrollment has successfully concluded in its multi-center, international CE mark clinical trials MEND ...

Home October 16, 2015
Home
Claret embolic protection, TAVR, cerebral protection
Feature | Heart Valve Technology

October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at ...

Home October 16, 2015
Home
ABSORB III trial, TCT 2015, bioresorbable vascular scaffold, BVS
Feature | Stents Bioresorbable

October 16, 2015 — Results from a clinical trial showed that Abbott's Absorb everolimus-eluting bioresorbable vascular ...

Home October 16, 2015
Home
News | Stents Bioresorbable

October 15, 2015 — Two new advances in stent technology announced in recent days further reinforce the effectiveness of ...

Home October 15, 2015
Home
PARTNER II Trial, TCT 2015, Edwards Lifesciences, Sapien 3 valve, one-year results
Feature | Heart Valve Technology

October 15, 2015 — One-year patient outcomes from the PARTNER II trial showed the low rate of 30-day complications with ...

Home October 15, 2015
Home
News | Stents Bioresorbable

October 15, 2015 — Biotronik has announced results from the BIOSOLVE-II trial, investigating the safety and clinical ...

Home October 15, 2015
Home
News | Drug-Eluting Balloons

October 15, 2015 — C. R. Bard Inc. announced the presentation of the 12-month results from the Lutonix Global Real-World ...

Home October 15, 2015
Home
Subscribe Now